← FDA DRUG APPROVALS
FDA ANDA · ANDA212025
APOMORPHINE HYDROCLORIDE
apomorphine hydrochloride
Sponsor: TP ANDA HOLDINGS
APPLICATION
ANDA212025
TYPE
ANDA
ORIGINAL APPROVAL
2022-02-23
LATEST ACTION
2022-02-23
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
APOMORPHINE HYDROCHLORIDEPrescription
APOMORPHINE HYDROCHLORIDE 30MG/3ML (10MG/ML) · INJECTABLE · SUBCUTANEOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.